Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Indegene IPO
Price Band
₹430.0–452.0
Issue Size
₹1841.76 Cr
Lot Size
33 shares
Min Investment
₹14,916
GMP
+₹275.0 (60.84%)
Issue Price
₹452.0
Subject to Sauda
₹6900
Paid only if allotted
Indegene IPO AI Summary
- Indegene IPO is listed on BSE, NSE in the Healthcare Research, Analytics & Technology sector.
- Price band: ₹430.0–₹452.0 per share, lot size 33 shares (min. investment ₹14,916).
- Subscription window: 06 May–08 May 2024, listing on 13 May 2024.
- Current GMP is +₹275.0 (60.84%), an estimated listing price of ₹727 — unofficial and can change daily.
Indegene Limited is a healthcare research and technology firm with a focus on digital services for the life sciences sector. The company is currently in the process of an IPO, with a price band of ₹430.0 to ₹452.0 and a minimum investment of ₹14,916.0. As of December 31, 2023, Indegene reported a total income of ₹1,969.75 Cr and a profit after tax of ₹241.90 Cr.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Indegene IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 08 May 2024 — not a current signal.
9 of 12 reviewers say Positive
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Indegene IPO Grey Market Premium (GMP) Today
GMP
+₹275.0
GMP %
+60.84%
Est. Listing
₹727.0
Updated: 25 Jul 2026 14:06
About the Company
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support. The company's services can be divided into following categories Enterprise Commercial Solutions Omnichannel Activation Enterprise Medical Solutions Enterprise Clinical Solutions and consultancy services The subsidiary of the company, DT Associates Limited, provides consulting services under the "DT Consulting" brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience. The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India. As of December 31, 2023, the company had 65 clients actively engaged with its services. As of December 31, 2023, the company employed 5,181 people worldwide. Of these, 4,461 are based in India, 530 work in North America, 105 in Europe, 73 in China, and 12 in other regions.
Company Financials (₹ Cr)
As of 2023-12-31
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 2,518.15 | 2,203.87 | 1,353.47 | 596.04 |
| Total Income | 1,969.75 | 2,364.10 | 1,690.50 | 996.92 |
| Profit After Tax | 241.90 | 266.10 | 162.82 | 149.41 |
| NET Worth | 1,327.00 | 1,063.72 | 763.90 | 324.51 |
| Reserves and Surplus | 1,282.65 | 1,019.43 | 763.55 | 324.19 |
| Total Borrowing | 399.33 | 394.34 | 18.24 | 24.76 |
Key Ratios
EPS
₹11.96
NAV
₹59.86
RoNW
18.23%
P/B Value
7.55
P/E Ratio
37.78
Market Cap
₹10814.07 Cr
PAT Margin
12.62%
Debt/Equity
0.30
Promoters
BCP Topco VII Pte.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Repayment/prepaymentof indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc 391.34 2 Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc. 102.92 3 General Corporate Purposes and Inorganic Growth 230.12
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total Income was ₹2,364.10 Cr in the period ending 31 Mar 2023, decreasing to ₹1,969.75 Cr by 31 Dec 2023. This decline is notable as the latter figure represents a 9-month period, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax was ₹266.10 Cr for the year ending 31 Mar 2023, which fell to ₹241.90 Cr by 31 Dec 2023. Similar to the revenue figures, this is a 9-month figure and not a full year, making direct comparison less straightforward.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO compared to its issue price. A positive GMP suggests that the market anticipates the stock will list at a higher price than the issue price, which can be a sign of strong demand.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their risk tolerance and investment goals. It's important to consider the company's fundamentals and market conditions.
Who May Want to Wait
Those who prefer stable investments with lower risk might want to avoid this IPO, as it may exhibit volatility in the short term. Investors should assess their financial situation and risk appetite before considering participation.
Listing Gains — The Risk
Listing-day gains can be influenced by market sentiment and demand for the stock. However, there is no guarantee that a stock will perform well on its first day of trading, and investors should be prepared for potential fluctuations in price.
This evaluation is generated from Indegene's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Indegene IPO GMP today?
Indegene IPO GMP today is +₹275.0 (60.84%), indicating an estimated listing price of ₹727. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Indegene IPO?
The price band of Indegene IPO is ₹430.0–₹452.0 per share.
When does Indegene IPO open and close?
Indegene IPO opens on 06 May 2024 and closes on 08 May 2024.
When does Indegene IPO list on the stock exchange?
Indegene IPO listed on 13 May 2024 at ₹727.0.
What is the lot size for Indegene IPO?
The lot size for Indegene IPO is 33 shares, requiring a minimum investment of ₹14,916.
What is the price band for the IPO?
The price band for the IPO is ₹430.0 to ₹452.0.
What is the minimum investment required?
The minimum investment required is ₹14,916.0.
What is the lot size for this IPO?
The lot size for this IPO is 33 shares.
When is the listing date for the IPO?
The listing date for the IPO is May 13, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium of the stock over its issue price in the grey market.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
06 May 2024
Close
08 May 2024
Allotment
09 May 2024
Listing
13 May 2024
Similar IPOs in Healthcare Research, Analytics & Technology
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Indegene?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.